跳至主要内容
临床试验/ACTRN12611000158965
ACTRN12611000158965招募中未知

International multi-site RCT of two versions of Group Schema Therapy compared to treatment as usual for Borderline Personality Disorder in reducing symptom severity and improving quality of life

Murdoch University0 个研究点目标入组 64 人开始时间: 2011年2月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • •1.Age 18-65 years
  • •2.Primary DSM-IV diagnosis of BPD (assessed with the SCID-II interview)
  • •3.BPD severity above 20 on the BPDSI interview
  • •4.Willingness to participate in the study (informed consent procedure)
  • •5.Ability to participate in (group) treatment and research for 2 years (e.g., no plans to move to another city).

排除标准

  • •1.Lifetime psychotic disorder (short stress-related episodes are allowed, as described in DSM-IV BPD criterion 9)
  • •2.IQ < 80 (in case of suspicion of low IQ, to be assessed with full intelligence test)
  • •3.Unable to read, speak, or write the language used at the site (in case of suspicion an official language test is to be used)
  • •4.Bipolar disorder type 1 (SCID-1)
  • •5.Dissociative Identity Disorder (confirmed by senior investigators)
  • •6.Full or sub-threshold (defined as one less than the number of criteria to qualify for the diagnosis) narcissistic or antisocial personality disorder (SCID-2)

研究者

相似试验